Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus

Richard A. Furie

Northwell, New Hyde Park, NY

Maria Dall’Era

University of California, San Francisco, San Francisco

Edward M. Vital

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom

Jay P. Garg

Genentech, South San Francisco, CA

Fedra Irazoque Palazuelos

Centro de Investigación y Tratamiento Reumatológico, Mexico City

Adolfina E. Zuta Santillán

Instituto de Ginecología y Reproducción, Lima, Peru

Jorge Ravelo-Hernández

Clínica San Juan Bautista, Unidad de Investigación en Reumatología e Inmunología, Lima, Peru

Mittermayer B. Santiago

Bahiana School of Medicine and Public Health, Salvador, Brazil

Beatriz Zazueta Montiel

Rheumatology Department, Hospital de Especialidades y Hospital de Gineco-Obstetricia No. 3 del Centro Médico Nacional La Raza, Mexico City

Stella Botha

Winelands Medical Research Centre, Cape Town, South Africa

Piotr Leszczyński

Department of Internal Medicine and Metabolic Diseases, Poznan University of Medical Sciences, Poznań, Poland

Viviane Angelina de Souza

Sandra A. Sicsik

Hospital Universitario Facultad de Medicina, Universidad Autónoma de Coahuila, Torreón, Mexico

Luis Bellatin

Hogar Clínica San Juan de Dios Arequipa, Cayma, Peru

Asokan Naidoo

Netcare uMhlanga Medical Centre, Durban, South Africa

Zahir Amoura

Sorbonne Université, Paris

Maria Antonietta D’Agostino

Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Rome

Sunil Kumar

Biruh Workeneh

University of Texas M.D. Anderson Cancer Center, Houston

Julie Rae

Genentech, South San Francisco, CA

Huiyan A. Mao

Hoffmann–La Roche, Mississauga, ON, Canada

Felix Erblang

F. Hoffmann–La Roche, Basel, Switzerland

Oliver Meier

F. Hoffmann–La Roche, Basel, Switzerland

Justine C. Maller

Genentech, South San Francisco, CA

Anca D. Askanase

Columbia University Irving Medical Center, New York